Tuesday, October 30, 2007

October 30, 2007

12:10: The Health Roundup with Rick and Jamie.

12:20: Halloween is just about here and this year Canadian Family Magazine has some great last minute tips and ideas to help make it that much more enjoyable for both you and your kids. We’’re talking about 3 amazing pumpkin projects, Halloween treats and more.
Guest: Jen Reynolds, Editor in Chief, Canadian Family Magazine.

12:35: A visit with Dr. Joyce Tellier.
Guest: Dr. Joyce Tellier, Naturopathic doctor over at Webber natural pharmaceuticals.

12:45: DayNight Pharmacy segment.
Guest: Hilton.

Hilton talked about Bill 102, Transparent Drug System for Patients Act 2006.

The Government's plan includes:

  • Achieving significant savings through volume discounts for all drugs purchased for the Ontario drug benefit Program
  • Improving patient access to drugs through new conditional listings, exceptional access and rapid reviews of innovative drugs
  • Listening to the views of Ontarians through a new Citizen's Council that will advise the Ministry on the social aspects of drug policies and priorities
  • Strengthening transparency by giving patients a role in drug listing decisions of the Committee to Evaluate drugs
  • Recognizing the valuable role of pharmacists in patient care by paying them for enhanced patient counseling and other professional services
  • Utilizing the expertise of Ontario's pharmacists through a new Pharmacy Council to advise the Ministry and the Executive Officer of the public drug programs
  • Freeing doctors of the burden of paperwork associated with Section 8 drugs.
On April 13, 2006 the Ministry introduced Bill 102. This Bill has significant and far-reaching consequences for pharmacists in Ontario and for pharmacists in Canada. It is important to recognize that the Bill itself is primarily enabling legislation with many details still to be worked out. The Bill also accompanied policy statements from the Ministry and both the Act that need to be looked at together. Some of the proposals have the potential to be incorporated into the National Pharmaceutical Strategy.

Product discussed: Salba, powerful whole food.

No comments: